REYKJAVIK, ICELAND AND BURGDORF, SWITZERLAND (JULY 9, 2025) – Alvotech (NASDAQ: ALVO SDB), a global biotech company specializing in the development and manufacturing of biosimilars for patients worldwide, today announced the expansion of its assembly and packaging capabilities through the acquisition of Ivers-Lee Group (“Ivers-Lee”), a family-owned company in Burgdorf, Switzerland, specializing in the provision of high-quality assembly and packaging services to the pharmaceutical sector. While Ivers-Lee will remain a separate legal entity, its activities will be integrated into Alvotech’s Technical Operations division to support Alvotech’s ambitious growth plans. To the press release
REYKJAVIK, ICELAND AND BURGDORF, SWITZERLAND (JULY 9, 2025) – Alvotech (NASDAQ: ALVO SDB), a global biotech company specializing in the development and manufacturing of biosimilars for patients worldwide, today announced the expansion of its assembly and packaging capabilities through the acquisition of Ivers-Lee Group (“Ivers-Lee”), a family-owned company in Burgdorf, Switzerland, specializing in the provision of high-quality assembly and packaging services to the pharmaceutical sector. While Ivers-Lee will remain a separate legal entity, its activities will be integrated into Alvotech’s Technical Operations division to support Alvotech’s ambitious growth plans.
To the press release